Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease
Dekkers, Claire C J, Wheeler, David C, Sjöström, C David, Stefansson, Bergur V, Cain, Valerie, Heerspink, Hiddo J LLanguage:
english
Journal:
Nephrology Dialysis Transplantation
DOI:
10.1093/ndt/gfx350
Date:
January, 2018
File:
PDF, 478 KB
english, 2018